These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2509126)

  • 21. Flosequinan, a new vasodilator: systemic and coronary hemodynamics and neuroendocrine effects in congestive heart failure.
    Cavero PG; De Marco T; Kwasman M; Lau D; Liu M; Chatterjee K
    J Am Coll Cardiol; 1992 Dec; 20(7):1542-8. PubMed ID: 1452928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodynamic and clinical significance of the pulmonary vascular response to long-term captopril therapy in patients with severe chronic heart failure.
    Packer M; Lee WH; Medina N; Yushak M
    J Am Coll Cardiol; 1985 Sep; 6(3):635-45. PubMed ID: 2993397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MDL 17,043: short- and long-term cardiopulmonary and clinical effects in patients with heart failure.
    Rubin SA; Tabak L
    J Am Coll Cardiol; 1985 Jun; 5(6):1422-7. PubMed ID: 3158690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nifedipine in congestive heart failure: effects on resting and exercise hemodynamics and regional blood flow.
    Leier CV; Patrick TJ; Hermiller J; Pacht KD; Huss P; Magorien RD; Unverferth DV
    Am Heart J; 1984 Dec; 108(6):1461-8. PubMed ID: 6507242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of molsidomine on the hemodynamics of patients with chronic heart failure at rest and during exercise.
    Larbig DT; Milstrey HR; Nasse H; Kahle T
    Am Heart J; 1985 Mar; 109(3 Pt 2):688-90. PubMed ID: 3883738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined hemodynamic effects of nifedipine and nitroglycerin in congestive heart failure.
    Kubo SH; Fox SC; Prida XE; Cody RJ
    Am Heart J; 1985 Nov; 110(5):1032-4. PubMed ID: 3933315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of acute and chronic minoxidil administration on rest and exercise hemodynamics and clinical status in patients with severe, chronic heart failure.
    Nathan M; Rubin SA; Siemienczuk D; Swan HJ
    Am J Cardiol; 1982 Nov; 50(5):960-6. PubMed ID: 7137047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological mechanisms for left ventricular unloading in clinical congestive heart failure. Differential effects of nitroprusside, phentolamine, and nitroglycerin on cardiac function and peripheral circulation.
    Miller RR; Vismara LA; Williams DO; Amsterdam EA; Mason DT
    Circ Res; 1976 Jul; 39(1):127-33. PubMed ID: 819179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the haemodynamic profiles of elgodipine and nicardipine in the anaesthetized dog.
    Drieu la Rochelle CD; Grosset A; O'Connor SE
    Br J Pharmacol; 1994 Jan; 111(1):49-56. PubMed ID: 8012724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Acute hemodynamic effects of nicardipine in patients with chronic congestive heart failure].
    Tondi S; Zennaro RG; Masciocco L; Mattioli G
    Cardiologia; 1989 Dec; 34(12):1013-9. PubMed ID: 2634477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous nicardipine in patients with chronic heart failure: a nuclear stethoscope study.
    Lahiri A; Robinson CW; Tovey J; Caruana MP; Kohli RS; Harlow BJ; Raftery EB
    Postgrad Med J; 1984; 60 Suppl 4():35-8. PubMed ID: 6527978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arterial vasodilator therapy in heart failure: haemodynamic response patterns predictive of changes in exercise capacity.
    Tan LB; Fox Y; Littler WA
    J Cardiovasc Pharmacol; 1989 Dec; 14(6):862-8. PubMed ID: 2481774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic, haemodynamic and radionuclide studies with nicardipine in coronary artery disease.
    Silke B; Graham DJ; Verma SP; Reynolds G; Frais MA; Finlayson JR; Taylor SH
    Eur J Clin Pharmacol; 1986; 29(6):651-7. PubMed ID: 3709609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemodynamic effects of vasodilators and long-term response in heart failure.
    Franciosa JA; Dunkman WB; Leddy CL
    J Am Coll Cardiol; 1984 Jun; 3(6):1521-30. PubMed ID: 6325522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta blockade in congestive heart failure: persistent adverse haemodynamic effects during chronic treatment with subsequent doses.
    Kukin ML; Kalman J; Mannino MM; Buchholz-Varley C; Ocampo O
    Heart; 1997 Nov; 78(5):444-9. PubMed ID: 9415001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sublingual nifedipine: acute effects in severe chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy.
    Miller AB; Conetta DA; Bass TA
    Am J Cardiol; 1985 May; 55(11):1359-62. PubMed ID: 3993570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The acute haemodynamic effects of nicardipine in patients with chronic left ventricular failure.
    Greenbaum RA; Wan S; Evans TR
    Eur J Clin Pharmacol; 1986; 30(4):383-6. PubMed ID: 3743613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of nitroglycerin on supine and upright exercise in mitral stenosis.
    Bornheimer JF; Kim JS; Sambasivan V; Biegler TL
    Am Heart J; 1982 Dec; 104(6):1288-93. PubMed ID: 6816056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haemodynamic dose-response effects of i.v. nicardipine in coronary artery disease.
    Silke B; Verma SP; Nelson GI; Hussain M; Taylor SH
    Br J Clin Pharmacol; 1984 Nov; 18(5):717-24. PubMed ID: 6508981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term outpatient vasodilator therapy of congestive heart failure. Consideration of agents at rest and during exercise.
    Chatterjee K; Massie B; Rubin S; Gelberg H; Brundage BH; Ports TA
    Am J Med; 1978 Jul; 65(1):134-45. PubMed ID: 99031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.